Navigation Links
GenVault Opens Japanese Subsidiary to Better Address Global Biobanking Market Growth
Date:1/26/2009

GenVault's energy and space efficient technologies ideally suit the needs of the Japanese Biobanking community, and create a new paradigm for eco-friendly, sustainable Biobanking initiatives.

CARLSBAD, Calif., Jan. 26 /PRNewswire/ -- GenVault Corporation today announces the opening of its newly-formed Japanese subsidiary in order to better serve the needs of the expanding Biobanking market and its growing customer base in Japan. GenVault Japan KK will be responsible for the marketing, selling and technical support of the full range of GenVault products and services in Japan.

GenVault is also delighted to announce that Mr. Junya Tominaga has joined the company in the role of Managing Director, GenVault Japan. Mr. Tominaga has over twenty years of senior management experience in the Japanese life science market place, most recently serving as the Managing Director of Illumina, Japan. Prior to this Mr. Tominaga held positions as Managing Director of Molecular Dynamics Japan and Clontech Japan.

"GenVault is very excited to be establishing a direct presence in Japan. We feel our products and technologies are particularly well suited for use in Japan, and bring strong advantages in terms of space and energy savings. We look forward to serving the needs of our Japanese customers," commented Mark J. Sutherland, Sr. Vice-President of Business Development for GenVault Corporation.

GenVault Japan is located in the ARK Mori Building in the Akasaka district of Tokyo and can be contacted at TEL: +81 (03) 4360-8225 and FAX +81 (03) 4360-8201

About GenVault

GenVault is the global leader in providing biosample workflow, transport, and storage solutions for genomic medicine, discovery and identification. Today, GenVault is empowering over 150 pharmaceutical companies, medical centers, academic institutions and law enforcement agencies to more fully leverage the rapidly growing genomics industry. As a scalable and reliable alternative to traditional freezers and DNA purification systems, the company's dry-state platform enables the extraction, preservation, recovery, and distribution of DNA at room temperature. Future systems will also accommodate proteins and RNA to provide a comprehensive solution. From GenPlate to the Dynamic Archive, GenVault is continuously developing and refining best practices for DNA sample management and preservation. For more information visit GenVault at www.genvault.com.

Contact: Bret Dash

Tel : 760 717 3774

bdash@genvault.com


'/>"/>
SOURCE GenVault Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. GenVault to Present at the BIOCOM Investor Conference
2. Mark Sutherland Joins GenVault as Senior Vice President, Business Development
3. GenVault Corporation Launches GenTegra(TM) DNA
4. GenVault Expands Scientific Advisory Board
5. Paul J. Mirabella, President and CEO of Naviscan PET Systems Inc., Joins GenVaults Board of Directors
6. Mark Ostrowski Joins GenVault as Vice President of Sales and Marketing
7. McGill University Purchases GenVaults Personal Archive System to Manage Rare Cancer Samples
8. GenVault and the National Center for Forensic Science to Present Novel Technology for Room Temperature Storage of RNA
9. David Barker, Former Illumina CSO, Joins GenVaults Scientific Advisory Board
10. GenVault Partnership with Genome Quebec Brings $3.3 Million Sale of Dynamic Archive Product
11. DuPont Opens Research & Development Center in India
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)... ... March 21, 2017 , ... Functional near-infrared spectroscopy (fNIRS), an ... explored as a way to track the brain’s response to acute pain in adults ... cold pressor test ,” published today in the journal Neurophotonics , by ...
(Date:3/22/2017)... -- Personal Genome Diagnostics Inc. (PGDx) today announced an ... U.S. Department of Veterans Affairs (VA) that replaces ... new CancerSELECT ™ 125 test. CancerSELECT 125 ... that includes microsatellite instability status (MSI), a biomarker ... inhibitor immunotherapies. CancerSELECT 125 will be available to ...
(Date:3/20/2017)... ... March 20, 2017 , ... ... of endogenous hormones to regulate homeostasis via their cognate nuclear receptors. By ... adverse reproductive, neurological, proliferative, and immunological disorders. EDC exposure can occur directly, ...
(Date:3/20/2017)... ... March 20, 2017 , ... Charm Sciences, Inc. ... play system that counts Peel Plate microbial test colonies, stores plate images, exports ... unit has an internal computer, and is accurate within 10% of an experienced ...
Breaking Biology Technology:
(Date:3/2/2017)... 2, 2017 Australian stem cell and regenerative ... has signed an agreement with the Monash Lung Biology ... Discovery Institute and Department of Pharmacology at Monash University, ... preclinical study to support the use of Cymerus™ mesenchymal ... Asthma is a chronic, long term lung ...
(Date:2/27/2017)... Strategic Cyber Ventures , the industry,s first cybersecurity focused ... investment in  Polarity , the first commercial human memory-augmentation ... and is led by cybersecurity veterans Tom Kellermann ... , also a longtime cybersecurity veteran and founder of ... round of funding. This new funding will be used ...
(Date:2/21/2017)... Der weltweite Biobanking-Sektor wird bis ... Gespräch mit mehr als 50 Vertretern aus verschiedenen Branchen wurde ... um diese Prognose zu realisieren. ... Zu den Schwierigkeiten ... Mittel für die Biobank, die Implementierung Zeit sparender Technologien, ...
Breaking Biology News(10 mins):